サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1761881

ワクチン送達デバイスの世界市場調査レポート：産業分析、規模、シェア、成長、動向、2025年から2033年までの予測

Global Vaccine Delivery Devices Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

出版日
ページ情報
英文 162 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.89円
ワクチン送達デバイスの世界市場調査レポート：産業分析、規模、シェア、成長、動向、2025年から2033年までの予測
出版日: 2025年07月01日
発行: Value Market Research
ページ情報: 英文 162 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ワクチン送達デバイスの世界市場規模は、2024年の45億6,000万米ドルから2033年には87億7,000万米ドルに成長し、2026～2033年の予測期間中に7.54％の堅調な年間平均成長率（CAGR）を示すと予測されます。

ワクチン送達デバイス市場は、重要な公衆衛生戦略としてワクチン接種への世界の注目が高まっていることを背景に、大きな成長を遂げています。最近のCOVID-19パンデミックを含む感染症対策への継続的な取り組みにより、効率的かつ効果的なワクチン送達システムの重要性が浮き彫りになっています。政府や保健機関がワクチン接種キャンペーンを優先する中、注射器、自動注射器、注射針を使わないシステムなどの先進的送達装置に対する需要が急増しています。これらの機器は、ワクチン投与の効率を高めるだけでなく、患者の快適性とコンプライアンスを向上させ、最新のワクチン接種戦略に不可欠な要素となっています。市場の拡大が続く中、医療従事者や患者の進化するニーズに応えるには、技術革新とユーザー中心の設計を重視することが不可欠となります。

さらに、技術の進歩は、安全性と有効性の向上に焦点を当て、ワクチン送達デバイス市場における技術革新を促進しています。トラッキングやモニタリング機能など、デジタルヘルス技術を組み込んだスマート送達システムの開発が人気を集めています。このような技術革新により、ヘルスケアプロバイダは適切な投与量とワクチン接種スケジュールの遵守を確認できるようになり、最終的にワクチン接種プログラムの有効性が高まります。市場が発展するにつれ、ワクチン送達装置への技術の統合は、予防接種活動の将来を形作る上で極めて重要な役割を果たすようになり、ワクチンが効率的かつ効果的に人々に届くようになります。

さらに、世界ヘルスへの取り組みが重視されるようになり、新興感染症への迅速な対応が求められるようになったことも、ワクチン送達装置市場を形成しています。新しいワクチンが開発・導入されるにつれて、多用途で適応性の高い送達システムへの需要が高まります。ワクチン送達装置の生産と流通を迅速に拡大する能力は、公衆衛生上の課題に対処する上で不可欠となります。市場が成長を続ける中、技術革新への注力、利害関係者間の協力、世界の保健ニーズへの対応が成功の主要因となり、ワクチン送達デバイス市場は今後も持続的な成長を遂げることが期待されます。

当レポートは、様々な産業や市場に関する包括的かつ実用的な洞察を顧客に提供できるよう、綿密に作成されています。各レポートは、市場情勢を完全に理解するために、いくつかの重要な要素を含んでいます。

市場概要：定義、分類、産業の現状に関する概要など、市場に関する詳細なイントロダクション。

市場力学：市場成長に影響を与える主要促進要因・抑制要因・機会・課題を詳細に分析します。このセクションでは、技術の進歩、規制の変更、新たな動向などの要因を検証します。

セグメンテーション分析：製品タイプ、用途、エンドユーザー、地域などの基準に基づき、市場を明確なセグメントに内訳。この分析により、各セグメントの業績と将来性を明らかにします。

競合情勢：市場シェア、製品ポートフォリオ、戦略的イニシアティブ、財務実績など、主要市場参入企業の包括的評価。主要企業が採用する競合力学と主要戦略に関する考察を記載しています。

市場予測：過去のデータと現在の市場状況に基づき、一定期間における市場規模と成長動向を予測します。これには、定量的分析と将来の市場軌跡を示すグラフ表示が含まれます。

地域分析：地域による市場パフォーマンスを評価し、主要市場や地域動向を明らかにします。地域の市場力学とビジネス機会を理解するのに役立ちます。

新たな動向と機会：現在の市場動向と新たな市場動向、技術革新、潜在的な投資対象セグメントを特定します。将来の開発と成長展望に関する洞察を記載しています。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 ワクチン送達デバイス産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 産業動向
  • ポーターのファイブフォース分析
  • 市場の魅力分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原料分析
    • 原料リスト
    • 原料メーカー一覧
    • 主要原料の価格動向
  • 潜在的バイヤーリスト
  • マーケティングチャネル
    • 直接マーケティング
    • 間接マーケティング
    • マーケティングチャネル発展動向

第5章 ワクチン送達デバイスの世界市場分析：デバイス別

  • デバイス別概要
  • デバイス別過去・予測データ分析
  • 注射器
  • ジェットインジェクタ
  • マイクロニードル
  • エアロゾル/ドライ粉末吸入
  • 経鼻送達デバイス
  • 皮内投与デバイス

第6章 ワクチン送達デバイスの世界市場分析：投与経路別

  • 投与経路別概要
  • 投与経路別過去・予測データ分析
  • 皮内接種
  • 筋肉内ワクチン接種
  • 皮下接種
  • その他のワクチン接種

第7章 ワクチン送達デバイスの世界市場分析：流通チャネル別

  • 流通チャネル別概要
  • 流通チャネル別過去・予測データ分析
  • オンライン薬局
  • 小売薬局
  • 病院薬局
  • ワクチン接種センター

第8章 ワクチン送達デバイスの世界市場分析：エンドユーザー別

  • エンドユーザー別概要
  • エンドユーザー別過去・予測データ分析
  • 病院
  • クリニック
  • その他

第9章 ワクチン送達デバイスの世界市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米の売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州の売上分析
    • 概要、実績と予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他の欧州
  • アジア太平洋の売上分析
    • 概要、実績と予測
    • アジア太平洋：セグメント別
    • アジア太平洋：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他のアジア太平洋
  • ラテンアメリカの売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他のラテンアメリカ
  • 中東・アフリカの売上分析
    • 概要、実績と予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他の中東・アフリカ

第10章 ワクチン送達デバイス企業の競合情勢

  • ワクチン送達デバイス市場競合
  • パートナーシップ/提携/合意
  • 合併・買収
  • 新製品上市
  • その他の開発

第11章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • BD
  • 3M
  • West Pharmaceutical Services Inc.
  • Terumo Europe NV
  • Gerresheimer AG
  • Viatris Inc.
  • INOVIO Pharmaceuticals
  • PharmaJet
  • Corium LLC
  • Mystic Pharmaceuticals Limited
  • Halozyme Inc.
  • Vaxxas
  • Micropoint Technologies
  • Star Syringe Limited
  • Bespak Limited
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Devices (USD MN)
  • Syringes Market Sales By Geography (USD MN)
  • Jet Injectors Market Sales By Geography (USD MN)
  • Micro Needles Market Sales By Geography (USD MN)
  • Aerosol/Dry Powder Inhalation Market Sales By Geography (USD MN)
  • Intranasal Delivery Devices Market Sales By Geography (USD MN)
  • Intradermal Delivery Devices Market Sales By Geography (USD MN)
  • Analysis By Route of Administration (USD MN)
  • Intradermal Vaccination Market Sales By Geography (USD MN)
  • Intramuscular Vaccination Market Sales By Geography (USD MN)
  • Subcutaneous Vaccination Market Sales By Geography (USD MN)
  • Other Vaccinations Market Sales By Geography (USD MN)
  • Analysis By Distribution Channel (USD MN)
  • Online Pharmacies Market Sales By Geography (USD MN)
  • Retail Pharmacies Market Sales By Geography (USD MN)
  • Hospital Pharmacies Market Sales By Geography (USD MN)
  • Vaccination Centers Market Sales By Geography (USD MN)
  • Analysis By End-User (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Clinics Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Vaccine Delivery Devices Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Vaccine Delivery Devices Report
  • Market Research Process
  • Market Research Methodology
  • Global Vaccine Delivery Devices Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Devices
  • Market Attractiveness Analysis By Route of Administration
  • Market Attractiveness Analysis By Distribution Channel
  • Market Attractiveness Analysis By End-User
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Devices (USD MN)
  • Syringes Market Sales By Geography (USD MN)
  • Jet Injectors Market Sales By Geography (USD MN)
  • Micro Needles Market Sales By Geography (USD MN)
  • Aerosol/Dry Powder Inhalation Market Sales By Geography (USD MN)
  • Intranasal Delivery Devices Market Sales By Geography (USD MN)
  • Intradermal Delivery Devices Market Sales By Geography (USD MN)
  • Global Market Analysis By Route of Administration (USD MN)
  • Intradermal Vaccination Market Sales By Geography (USD MN)
  • Intramuscular Vaccination Market Sales By Geography (USD MN)
  • Subcutaneous Vaccination Market Sales By Geography (USD MN)
  • Other Vaccinations Market Sales By Geography (USD MN)
  • Global Market Analysis By Distribution Channel (USD MN)
  • Online Pharmacies Market Sales By Geography (USD MN)
  • Retail Pharmacies Market Sales By Geography (USD MN)
  • Hospital Pharmacies Market Sales By Geography (USD MN)
  • Vaccination Centers Market Sales By Geography (USD MN)
  • Global Market Analysis By End-User (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Clinics Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR11215563

Global Vaccine Delivery Devices Market size is anticipated to grow from USD 4.56 Billion in 2024 to USD 8.77 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 7.54% during the forecast period of 2026 to 2033.

The Vaccine Delivery Devices Market is experiencing significant growth, driven by the increasing global focus on vaccination as a critical public health strategy. The ongoing efforts to combat infectious diseases, including the recent COVID-19 pandemic, have underscored the importance of efficient and effective vaccine delivery systems. As governments and health organizations prioritize vaccination campaigns, the demand for advanced delivery devices, such as syringes, auto-injectors, and needle-free systems, is surging. These devices not only enhance the efficiency of vaccine administration but also improve patient comfort and compliance, making them essential components of modern vaccination strategies. As the market continues to expand, the emphasis on innovation and user-centric design will be crucial in meeting the evolving needs of healthcare providers and patients alike.

Moreover, advancements in technology are driving innovation within the Vaccine Delivery Devices Market, with a focus on improving safety and efficacy. The development of smart delivery systems that incorporate digital health technologies, such as tracking and monitoring capabilities, is gaining traction. These innovations enable healthcare providers to ensure proper dosage and adherence to vaccination schedules, ultimately enhancing the effectiveness of vaccination programs. As the market evolves, the integration of technology into vaccine delivery devices will play a pivotal role in shaping the future of immunization efforts, ensuring that vaccines reach populations efficiently and effectively.

Additionally, the increasing emphasis on global health initiatives and the need for rapid response to emerging infectious diseases are shaping the Vaccine Delivery Devices Market. As new vaccines are developed and deployed, the demand for versatile and adaptable delivery systems will rise. The ability to quickly scale up production and distribution of vaccine delivery devices will be essential in addressing public health challenges. As the market continues to grow, the focus on innovation, collaboration among stakeholders, and responsiveness to global health needs will be key drivers of success, positioning the Vaccine Delivery Devices Market for sustained growth in the years to come.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Devices

  • Syringes
  • Jet Injectors
  • Micro Needles
  • Aerosol/Dry Powder Inhalation
  • Intranasal Delivery Devices
  • Intradermal Delivery Devices

By Route of Administration

  • Intradermal Vaccination
  • Intramuscular Vaccination
  • Subcutaneous Vaccination
  • Other Vaccinations

By Distribution Channel

  • Online Pharmacies
  • Retail Pharmacies
  • Hospital Pharmacies
  • Vaccination Centers

By End-User

  • Hospitals
  • Clinics
  • Others
  • COMPANIES PROFILED
  • BD
  • 3M
  • West Pharmaceutical Services Inc.
  • Terumo Europe NV
  • Gerresheimer AG
  • Viatris Inc.
  • INOVIO Pharmaceuticals
  • PharmaJet
  • Corium LLC
  • Mystic Pharmaceuticals Limited
  • Halozyme Inc.
  • Vaxxas
  • Micropoint Technologies
  • Star Syringe Limited
  • Bespak Limited.
  • The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. VACCINE DELIVERY DEVICES INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Devices
    • 3.7.2 Market Attractiveness Analysis By Route of Administration
    • 3.7.3 Market Attractiveness Analysis By Distribution Channel
    • 3.7.4 Market Attractiveness Analysis By End-User
    • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL VACCINE DELIVERY DEVICES MARKET ANALYSIS BY DEVICES

  • 5.1. Overview By Devices
  • 5.2. Historical and Forecast Data Analysis By Devices
  • 5.3. Syringes Historic and Forecast Sales By Regions
  • 5.4. Jet Injectors Historic and Forecast Sales By Regions
  • 5.5. Micro Needles Historic and Forecast Sales By Regions
  • 5.6. Aerosol/Dry Powder Inhalation Historic and Forecast Sales By Regions
  • 5.7. Intranasal Delivery Devices Historic and Forecast Sales By Regions
  • 5.8. Intradermal Delivery Devices Historic and Forecast Sales By Regions

6. GLOBAL VACCINE DELIVERY DEVICES MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

  • 6.1. Overview By Route of Administration
  • 6.2. Historical and Forecast Data Analysis By Route of Administration
  • 6.3. Intradermal Vaccination Historic and Forecast Sales By Regions
  • 6.4. Intramuscular Vaccination Historic and Forecast Sales By Regions
  • 6.5. Subcutaneous Vaccination Historic and Forecast Sales By Regions
  • 6.6. Other Vaccinations Historic and Forecast Sales By Regions

7. GLOBAL VACCINE DELIVERY DEVICES MARKET ANALYSIS BY DISTRIBUTION CHANNEL

  • 7.1. Overview By Distribution Channel
  • 7.2. Historical and Forecast Data Analysis By Distribution Channel
  • 7.3. Online Pharmacies Historic and Forecast Sales By Regions
  • 7.4. Retail Pharmacies Historic and Forecast Sales By Regions
  • 7.5. Hospital Pharmacies Historic and Forecast Sales By Regions
  • 7.6. Vaccination Centers Historic and Forecast Sales By Regions

8. GLOBAL VACCINE DELIVERY DEVICES MARKET ANALYSIS BY END-USER

  • 8.1. Overview By End-User
  • 8.2. Historical and Forecast Data Analysis By End-User
  • 8.3. Hospitals Historic and Forecast Sales By Regions
  • 8.4. Clinics Historic and Forecast Sales By Regions
  • 8.5. Others Historic and Forecast Sales By Regions

9. GLOBAL VACCINE DELIVERY DEVICES MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2 North America By Segment Sales Analysis
    • 9.3.3 North America By Country Sales Analysis
    • 9.3.4 United States Sales Analysis
    • 9.3.5 Canada Sales Analysis
    • 9.3.6 Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2 Europe By Segment Sales Analysis
    • 9.4.3 Europe By Country Sales Analysis
    • 9.4.4 United Kingdom Sales Analysis
    • 9.4.5 France Sales Analysis
    • 9.4.6 Germany Sales Analysis
    • 9.4.7 Italy Sales Analysis
    • 9.4.8 Russia Sales Analysis
    • 9.4.9 Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2 Asia Pacific By Segment Sales Analysis
    • 9.5.3 Asia Pacific By Country Sales Analysis
    • 9.5.4 China Sales Analysis
    • 9.5.5 India Sales Analysis
    • 9.5.6 Japan Sales Analysis
    • 9.5.7 South Korea Sales Analysis
    • 9.5.8 Australia Sales Analysis
    • 9.5.9 South East Asia Sales Analysis
    • 9.5.10 Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2 Latin America By Segment Sales Analysis
    • 9.6.3 Latin America By Country Sales Analysis
    • 9.6.4 Brazil Sales Analysis
    • 9.6.5 Argentina Sales Analysis
    • 9.6.6 Peru Sales Analysis
    • 9.6.7 Chile Sales Analysis
    • 9.6.8 Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2 Middle East & Africa By Segment Sales Analysis
    • 9.7.3 Middle East & Africa By Country Sales Analysis
    • 9.7.4 Saudi Arabia Sales Analysis
    • 9.7.5 UAE Sales Analysis
    • 9.7.6 Israel Sales Analysis
    • 9.7.7 South Africa Sales Analysis
    • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE VACCINE DELIVERY DEVICES COMPANIES

  • 10.1. Vaccine Delivery Devices Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11. COMPANY PROFILES OF VACCINE DELIVERY DEVICES INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. BD
    • 11.3.1 Company Overview
    • 11.3.2 Company Revenue
    • 11.3.3 Products
    • 11.3.4 Recent Developments
  • 11.4. 3M
    • 11.4.1 Company Overview
    • 11.4.2 Company Revenue
    • 11.4.3 Products
    • 11.4.4 Recent Developments
  • 11.5. West Pharmaceutical Services Inc.
    • 11.5.1 Company Overview
    • 11.5.2 Company Revenue
    • 11.5.3 Products
    • 11.5.4 Recent Developments
  • 11.6. Terumo Europe NV
    • 11.6.1 Company Overview
    • 11.6.2 Company Revenue
    • 11.6.3 Products
    • 11.6.4 Recent Developments
  • 11.7. Gerresheimer AG
    • 11.7.1 Company Overview
    • 11.7.2 Company Revenue
    • 11.7.3 Products
    • 11.7.4 Recent Developments
  • 11.8. Viatris Inc.
    • 11.8.1 Company Overview
    • 11.8.2 Company Revenue
    • 11.8.3 Products
    • 11.8.4 Recent Developments
  • 11.9. INOVIO Pharmaceuticals
    • 11.9.1 Company Overview
    • 11.9.2 Company Revenue
    • 11.9.3 Products
    • 11.9.4 Recent Developments
  • 11.10. PharmaJet
    • 11.10.1 Company Overview
    • 11.10.2 Company Revenue
    • 11.10.3 Products
    • 11.10.4 Recent Developments
  • 11.11. Corium LLC
    • 11.11.1 Company Overview
    • 11.11.2 Company Revenue
    • 11.11.3 Products
    • 11.11.4 Recent Developments
  • 11.12. Mystic Pharmaceuticals Limited
    • 11.12.1 Company Overview
    • 11.12.2 Company Revenue
    • 11.12.3 Products
    • 11.12.4 Recent Developments
  • 11.13. Halozyme Inc.
    • 11.13.1 Company Overview
    • 11.13.2 Company Revenue
    • 11.13.3 Products
    • 11.13.4 Recent Developments
  • 11.14. Vaxxas
    • 11.14.1 Company Overview
    • 11.14.2 Company Revenue
    • 11.14.3 Products
    • 11.14.4 Recent Developments
  • 11.15. Micropoint Technologies
    • 11.15.1 Company Overview
    • 11.15.2 Company Revenue
    • 11.15.3 Products
    • 11.15.4 Recent Developments
  • 11.16. Star Syringe Limited
    • 11.16.1 Company Overview
    • 11.16.2 Company Revenue
    • 11.16.3 Products
    • 11.16.4 Recent Developments
  • 11.17. Bespak Limited
    • 11.17.1 Company Overview
    • 11.17.2 Company Revenue
    • 11.17.3 Products
    • 11.17.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies